Children treated with dupilumab for severe atopic dermatitis should not receive live attenuated vaccines, including boosters, without careful consideration of risks and the involvement of pediatric subspecialists.
Children treated with dupilumab for severe atopic dermatitis should not receive live attenuated vaccines, including boosters, without careful consideration of risks and the involvement of pediatric subspecialists.
Children treated with dupilumab...